Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BOTdesign is a French digital health and medtech company that develops advanced artificial intelligence and software solutions to optimize patient care pathways and accelerate clinical research. The company's flagship offerings include HEKO (formerly MAX), a secure, certified medical device platform for pre-diagnosis, clinical follow-up, and patient-caregiver communication, and ORIGA, a generative AI platform that creates realistic synthetic patient cohorts to augment clinical trial data. By leveraging deep learning and secure health data hosting (HDS), BOTdesign helps healthcare providers reduce administrative burdens and enables pharmaceutical and dermo-cosmetic companies to conduct more robust, cost-effective clinical studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BotDesign.